This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Marsh & McLennan Unit Launches Cloud-Based Tech Solution
by Zacks Equity Research
Marsh & McLennan (MMC) arm Mercer introduces Mercer Mobility Management Platform in partnership with ServiceNow.
3 Reasons Growth Investors Will Love eHealth (EHTH)
by Zacks Equity Research
eHealth (EHTH) could produce exceptional returns because of its solid growth attributes.
Analysts Estimate eHealth (EHTH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
eHealth (EHTH) Up 259% in a Year: What's Driving the Stock?
by Zacks Equity Research
Shares of eHealth (EHTH) is expected to continue the bull run backed by solid fundamentals and initiatives to ramp up growth.
EHealth (EHTH) Misses Q4 Earnings Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -18.27% and 0.19%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
EHealth (EHTH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Momentum Investors Will Love eHealth (EHTH)
by Zacks Equity Research
Does eHealth (EHTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Marsh & McLennan (MMC) in Focus: Stock Moves 5.3% Higher
by Zacks Equity Research
Marsh & McLennan (MMC) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
eHealth (EHTH) Catches Eye: Stock Jumps 6.4%
by Zacks Equity Research
eHealth (EHTH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
eHealth (EHTH) Reports Preliminary Results for Q4 and FY18
by Zacks Equity Research
eHealth expects Q4 net income between $24.3 million and $27.3 million on revenues of $133.5 million to $135.5 million.
CME Group Gains 26% in a Year: Will the Rally Continue?
by Zacks Equity Research
Shares of CME Group (CME) rally 26.1% in a year, backed by solid fundamentals and initiatives to ramp up growth.
Diversified Business, Buyouts to Aid Allstate's Growth in 2019
by Zacks Equity Research
Allstate's (ALL) diversified portfolio along with recent acquisitions position it for growth in 2019.
Why You Should Keep Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Banking on top-line improvement, inorganic growth and strong liquidity, Marsh & McLennan (MMC) holds great potential to garner heavy returns for investors.
eHealth's Medicare Application Businesses Offer a Big Boost
by Zacks Equity Research
Robust commission revenues, medicare application business and a probable expansion of enrollment volume help eHealth (EHTH) emerge as a prospective bet for yield-seeking investors.
Marsh & McLennan's (MMC) Unit Launches China Desk in Dubai
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary introduces China desk in Dubai to benefit from the growing commercial links amid China, the Middle East and Africa.
The Zacks Analyst Blog Highlights: Cincinnati Financial, National General, State Auto, Arthur J. and eHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cincinnati Financial, National General, State Auto, Arthur J. and eHealth
5 Insurance Stocks Set to Keep Winning Streak Alive in 2019
by Zacks Equity Research
We zeroed on five solid picks set to keep the growth momentum alive in 2019 banking on operational efficiency and favorable macro backdrop.
Here's Why You Should Buy Willis Towers Watson Stocks Now
by Zacks Equity Research
Willis Towers Watson's (WLTW) organic growth, momentum in the exchange business and strong capital position make the stock apt to buy.
Arthur J. Gallagher Gains 18% YTD: Will the Rally Continue?
by Zacks Equity Research
Shares of Arthur J. Gallagher & Co. (AJG) rallied 18% year to date, backed by solid fundamentals and initiatives to ramp up growth.
Marsh & McLennan's Arm Acquires Otis-Magie Insurance Agency
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary purchases Otis-Magie Insurance Agency to enrich customer experience in northern Minnesota.
Arthur J. Gallagher Expands Globally With Boston Marks Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Boston Marks with operations in New Zealand, Australia and United Kingdom is in tandem with growing international footprint.
New Strong Buy Stocks for December 7th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Marsh & McLennan's (MMC) Unit Closes Pavilion Acquisition
by Zacks Equity Research
Marsh & McLennan's (MMC) arm wraps up the pending purchase of Pavilion to enrich customer experiences.
Aon Issues Unsecured Notes, Gets Rating Actions From Moody's
by Zacks Equity Research
Aon (AON) issued senior unsecured notes get rating affirmations from Moody's. Outlook remains stable.
Arthur J. Gallagher Buyout to Brace Central California Base
by Zacks Equity Research
Arthur J. Gallagher (AJG) steadily ramps up its inorganic growth profile, this time with Buckman-Mitchell buyout.